FNBP4 activators are a category of molecules that specifically target and increase the biological activity of the Formin-Binding Protein 4 (FNBP4). FNBP4 is a part of the formin-binding protein family, which is known to play a role in the regulation of the actin cytoskeleton within cellular biology. The activators of FNBP4 facilitate its function by bolstering its ability to interact with other proteins or by stabilizing its active conformation. These chemical activators can bind to different domains of the FNBP4 protein, which can result in the enhancement of its natural activity, potentially affecting the dynamics of actin assembly and disassembly.
The structural makeup of FNBP4 activators is diverse, reflecting the complexity of the protein's activation mechanisms. These chemical entities are often carefully designed small molecules that can permeate the cell membrane to reach intracellular targets like FNBP4. They may interact with the protein at allosteric sites, which are locations on the protein surface that are distinct from the primary active site but still capable of modulating the protein's function when occupied by a ligand. Alternatively, these activators may bind directly to the primary active site, thereby promoting the protein's interaction with actin or other regulatory components. To achieve this, FNBP4 activators often mimic or enhance the action of endogenous molecules that interact with FNBP4, or they might induce a structural shift in FNBP4 that leads to a more active form of the protein. The interactions between the activators and FNBP4 are governed by precise molecular forces, including hydrogen bonds, ionic interactions, and van der Waals forces, which are critical for the specificity and strength of the activation effect. Through detailed structure-activity relationship studies, these molecules are optimized to ensure they possess the necessary properties to effectively and selectively activate FNBP4.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and can enhance actin polymerization, which may indirectly activate FNBP4 by promoting actin cytoskeleton reorganization. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Stabilizes actin filaments and could indirectly increase FNBP4 activity by enhancing actin filament stability. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitor of Rho-associated protein kinase (ROCK), leading to changes in actin organization which FNBP4 might be involved in. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and possibly leading to cytoskeletal changes involving FNBP4. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
A compound that disrupts actin dimers and can lead to changes in actin dynamics that FNBP4 may be responsive to. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Inhibits protein kinase C, potentially modifying actin dynamics and indirectly influencing FNBP4 activity. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II activity and can lead to changes in actin cytoskeleton organization that FNBP4 could be responsive to. | ||||||